4//SEC Filing
Peyer James 4
Accession 0001415889-25-014483
CIK 0001829802other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:30 PM ET
Size
6.3 KB
Accession
0001415889-25-014483
Insider Transaction Report
Form 4
Peyer James
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2025-05-21+19,000→ 19,000 total(indirect: See footnote)Exercise: $0.32Exp: 2035-05-20→ Common Stock (19,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or May 21, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
- [F2]These options are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the options, and shares exercisable thereunder, held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such options.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001843594
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:30 PM ET
- Size
- 6.3 KB